JP2024527537A5 - - Google Patents

Info

Publication number
JP2024527537A5
JP2024527537A5 JP2023580373A JP2023580373A JP2024527537A5 JP 2024527537 A5 JP2024527537 A5 JP 2024527537A5 JP 2023580373 A JP2023580373 A JP 2023580373A JP 2023580373 A JP2023580373 A JP 2023580373A JP 2024527537 A5 JP2024527537 A5 JP 2024527537A5
Authority
JP
Japan
Prior art keywords
immune effector
effector cells
seq
target portion
hla
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023580373A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024527537A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2022/103102 external-priority patent/WO2023274387A1/zh
Publication of JP2024527537A publication Critical patent/JP2024527537A/ja
Publication of JP2024527537A5 publication Critical patent/JP2024527537A5/ja
Pending legal-status Critical Current

Links

JP2023580373A 2021-07-01 2022-06-30 Ｇｄ２を標的とするユニバーサルｃａｒ－ｔ細胞及びその製造方法並びに使用 Pending JP2024527537A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN202110749475 2021-07-01
CN202110749475.0 2021-07-01
PCT/CN2022/103102 WO2023274387A1 (zh) 2021-07-01 2022-06-30 靶向gd2的通用型car-t细胞及其制备方法和应用

Publications (2)

Publication Number Publication Date
JP2024527537A JP2024527537A (ja) 2024-07-25
JP2024527537A5 true JP2024527537A5 (https=) 2025-07-07

Family

ID=84690472

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023580373A Pending JP2024527537A (ja) 2021-07-01 2022-06-30 Ｇｄ２を標的とするユニバーサルｃａｒ－ｔ細胞及びその製造方法並びに使用

Country Status (4)

Country Link
US (1) US20240139321A1 (https=)
JP (1) JP2024527537A (https=)
CN (1) CN118019842A (https=)
WO (1) WO2023274387A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025219520A1 (en) * 2024-04-18 2025-10-23 Match Medicines Gmbh MODIFIED HUMAN T CELL WITH A REDUCED HLA-Ia REPERTOIRE AND METHOD OF PRODUCTION

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10391126B2 (en) * 2011-11-18 2019-08-27 Board Of Regents, The University Of Texas System CAR+ T cells genetically modified to eliminate expression of T-cell receptor and/or HLA
US20190048085A1 (en) * 2016-02-25 2019-02-14 Cell Medica Switzerland Ag Modified cells for immunotherapy
MX2019013514A (es) * 2017-05-12 2020-01-20 Crispr Therapeutics Ag Materiales y metodos para modificar celulas por ingenieria genetica y usos de los mismos en inmunooncologia.
CN109456943A (zh) * 2017-09-06 2019-03-12 亘喜生物科技（上海）有限公司 通用型嵌合抗原受体t细胞制备技术
CN107630006B (zh) * 2017-09-30 2020-09-11 山东兴瑞生物科技有限公司 一种制备tcr与hla双基因敲除的t细胞的方法
CN107723275B (zh) * 2017-10-20 2020-09-04 重庆精准生物技术有限公司 通用型car-t细胞及其制备方法和应用
CN108728460A (zh) * 2018-05-25 2018-11-02 上海恒润达生生物科技有限公司 靶向gd2的嵌合抗原受体及其用途
AU2020418199B2 (en) * 2020-01-02 2024-06-13 Ningbo T-Maximum Biopharmaceuticals Co., Ltd. Modified immune effector cell and preparation method therefor

Similar Documents

Publication Publication Date Title
US20250136700A1 (en) Bispecific antibody for cancer immunotherapy
US20220047633A1 (en) Cd22 chimeric antigen receptor (car) therapies
US20210347851A1 (en) Cd19 chimeric antigen receptor (car) and cd22 car combination therapies
TWI854953B (zh) 抗ｃｄ３抗體及含有該抗體的分子、及其製造方法
JP2023530408A (ja) Ｃｄ７０指向性がん免疫療法のための遺伝子修飾されたナチュラルキラー細胞
JP7399852B2 (ja) 多重特異性抗体とその作製及び使用方法
TW202340473A (zh) 利用嵌合抗原受體之癌症治療
JP6608698B2 (ja) Ｐ２ｘ７受容体アンタゴニスト及びアゴニスト
CN112028996A (zh) 靶向bcma的单域抗体及其用途
KR20220035367A (ko) 항-dll3 키메라 항원 수용체 및 이의 용도
JP2018504113A (ja) 共通軽鎖を有する二重特異性抗体又は抗体混合物
TW201708261A (zh) Ｄｌｌ３及ｃｄ３抗體構築體
WO2016197497A1 (zh) 一种抗pd-1的单克隆抗体及其获得方法
JP2019530431A5 (https=)
JP2022542559A5 (https=)
JP2024509910A (ja) Ｍａｇｅ－ａ４ペプチド－ｍｈｃ抗原結合タンパク質
JP2024516308A5 (https=)
WO2015172341A1 (zh) 针对磷脂酰肌醇蛋白多糖-3和t细胞抗原的双特异性抗体
JP2025532313A (ja) Ｃｄ３を標的とする抗体及びその用途
TW202346368A (zh) 具有增加的選擇性的多鏈多靶向性雙特異性抗原結合分子
JP2024527537A5 (https=)
JP2021072773A (ja) ｐ５３−ＭＨＣクラスＩ複合体に結合するＴ細胞受容体様抗体
JP2024527539A5 (https=)
WO2022002006A1 (zh) Fab-HCAb结构的结合蛋白
KR102393776B1 (ko) Cd22에 특이적인 인간화 항체 및 이를 이용한 키메라 항원 수용체